pharma-company /Medicinal products /Active ingredients

Rx · PZN 18155996

OPDUALAG 240 mg/80 mg concentrate for preparation of a solution for infusion vial

German trade nameOPDUALAG 240 mg-80 mg Konzentrat zur Herstellung einer Infusionslösung Durchstechflasche

Active ingredientNivolumab and relatlimabSubstance (DE)Nivolumab und RelatlimabPharmaceutical formConcentrate for solution for infusion

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €6,114

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for OPDUALAG 240 mg/80 mg concentrate for preparation of a solution for infusion vial.

Review purchasing terms

OPDUALAG 240 mg/80 mg concentrate for preparation of a solution for infusion vial contains the active ingredient Nivolumab and relatlimab (German Nivolumab und Relatlimab) and comes as Concentrate for solution for infusion. One pack size is recorded (PZN 18155996). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability.


OPDUALAG 240 mg/80 mg concentrate for preparation of a solution for infusion vial was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.